Specifically, we asked whether there were genomic alterations associated with elevated activity of Hippo pathway co-activators YAP/TAZ, known to control pro-tumorigenic signals in multiple cancer types (Hiemer et al., 2015; Moroishi et al., 2015; Zanconato et al., 2016). Here, WWTR1 is linked to cancer.